Skip to main content
. 2019 Aug 9;9(8):63. doi: 10.1038/s41408-019-0223-7

Fig. 1.

Fig. 1

a Survival of an unselected MDS cohort (n = 1023) stratified by an ALC < or ≥1.2×109/l. b Survival of patients with primary MDS, without induction chemotherapy or stem cell transplantation stratified by an ALC < or ≥1.2 × 109/l. c Survival of patients with MDS-RS-SLD (n = 42) without induction chemotherapy or stem cell transplantation stratified by an ALC < or ≥1.2 × 109/l. d Survival of 265 patients with primary MDS and IPSS-R low-risk MDS, without induction chemotherapy or stem cell transplantation, stratified by an ALC < or ≥1.2 × 109/l